Background: We recently discovered an autosomal dominant disease causing a
progressive dementia. The disease is caused by a point mutation in the gene
coding for the serine protease inhibitor (ie, serpin) neuroserpin. The mut
ation results in an unstable neuroserpin protein that readily aggregates in
to intraneuronal inclusions that we identify as Collins bodies. The bodies
are distributed throughout the cerebral hemispheres but are significantly m
ore numerous in the cortex and the substantia nigra. We have named the dise
ase familial encephalopathy with neuroserpin inclusion bodies (FENIB),
Objectives: To describe the cognitive and neurophysiological changes exhibi
ted by individuals with FENIB and to correlate the phenotypic expression of
the disease with the neuropathological findings.
Design: Multiple case studies using neuropsychological assessment, electroe
ncephalography (EEG), magnetic resonance imaging (MRI), and single-photon e
mission computed tomographic (SPECT) studies of family members were perform
ed. Using these measures, we also compared family members in whom the mutat
ion is present with family members in whom the mutation was absent to contr
ol for nonspecific familial factors.
Subjects: Nine individuals (5 women, aged 31-64 years; 4 men, aged 43-67 ye
ars) from 2 generations of family members related to the first reliably ide
ntified individual with symptoms of this disease. Symptoms, by self-report
and reports of other family members, ranged from asymptomatic to severe dem
entia. Six of the 9 individuals carried the disease mutation.
Results: All subjects with the mutation demonstrated some cognitive changes
, with the greatest demonstrated by subjects older than 40 years. The chang
es included restricted attention, concentration, and response regulation fu
nctions, reduced controlled oral fluency (word-list generation), and restri
cted visuospatial organization. In general, recall memory was not as affect
ed as other cognitive domains. The most severely affected subject demonstra
ted global dementia with prominent frontal lobe features. Findings on SPECT
showed anomalies limited to frontal areas in the less affected subjects an
d more global, patchy areas of hypoperfusion in the more severely affected
subjects. The 3 oldest and most affected subjects demonstrated slowing on E
EG findings. The MRI findings were noncontributory except in the 2 most sev
ere cases, which showed global cortical atrophy.
Conclusions: Cognitive changes in mildly to moderately affected subjects we
re characterized by deficits in frontal and frontal-subcortical area-depend
ent processes. Continued progressive deterioration of cerebral functions wi
th relative sparing of recall memory suggests a unique dementia associated
with this disease.